You are here

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Artesia, California, 90701 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Primary Open Angle Glaucoma, Ocular Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of primary open-angle glaucoma (including pigmentary or pseudoexfoliative)
or ocular hypertension in 1 or both eyes.

- Qualifying intraocular pressure (IOP) in the same eye at the Eligibility 1 and 2
measurements.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Closed/barely open anterior chamber angle or a history of acute angle closure in
either eye.

- Anticipate the need to initiate or modify medication (systemic or topical) that is
known to affect intraocular pressure (IOP) during the study period.

NCT00572455
Pfizer
Completed
Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Open-Angle Glaucoma, Ocular Hypertension
NCT00150267
All Genders
18+
Years
Multiple Sites
Open Angle Glaucoma, Ocular Hypertension
NCT00140049
All Genders
18+
Years
Multiple Sites
Ocular Hypertension, Open-Angle Glaucoma
NCT00140062
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now